Fermer le menu


Member of Lyonbiopole


The goal of Prediction BioSciences is to discover, develop, and bring to patients therapeutics and diagnostics in the field of stroke and neurodegenerative diseases.

While the Company maintains R&D collaborations with numerous academic and industry partners throughout Europe and Asia, it launched Mosaic Neurosciences (Epalinges, CH) in May 2022 as a new R&D laboratory dedicated to neurodegenerative disorders such as Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS).


Strategic application domain: In Vitro diagnostic

Application market: Cardiology, Neurology & Mental Health Disorders

Type of activity: Diagnostics, Therapeutics, Pharma or Biotech

Technologies: Antibodies - Protein - Peptide, Drug delivery device & Technologies, Screening methods or services

Created on jan. 11th, 2010 - 3 employees



Bioparc Laennec
60A avenue Rockfeller 69008 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.